Literature DB >> 31722206

Template Activating Factor-I α Regulates Retroviral Silencing during Reprogramming.

Phuong Linh Bui1, Ken Nishimura2, Gonzalo Seminario Mondejar1, Arun Kumar1, Shiho Aizawa1, Kensaku Murano3, Kyosuke Nagata4, Yohei Hayashi5, Aya Fukuda1, Yasuko Onuma6, Yuzuru Ito6, Mahito Nakanishi6, Koji Hisatake7.   

Abstract

Reprogramming somatic cells to induced pluripotent stem cells (iPSCs) is accompanied by dramatic changes in epigenetic programs, including silencing of endogenous and exogenous retroviruses. Here, we utilized replication-defective and persistent Sendai virus (SeVdp)-based vectors to monitor retroviral silencing during reprogramming. We observed that retroviral silencing occurred at an early reprogramming stage without a requirement for KLF4 or the YY1-binding site in the retroviral genome. Insertional chromatin immunoprecipitation (iChIP) enabled us to isolate factors assembled on the silenced provirus, including components of inhibitor of histone acetyltransferase (INHAT), which includes the SET/TAF-I oncoprotein. Knockdown of SET/TAF-I in mouse embryonic fibroblasts (MEFs) diminished retroviral silencing during reprogramming, and overexpression of template activating factor-I α (TAF-Iα), a SET/TAF-I isoform predominant in embryonic stem cells (ESCs), reinforced retroviral silencing by an SeVdp-based vector that is otherwise defective in retroviral silencing. Our results indicate an important role for TAF-Iα in retroviral silencing during reprogramming.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  SeVdp vector; TAF-Iα; insertional chromatin immunoprecipitation; primer-binding site; reprogramming; retroviral silencing

Year:  2019        PMID: 31722206     DOI: 10.1016/j.celrep.2019.10.010

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  1 in total

1.  Human TAF-Iα promotes oncogenic transformation via enhancement of cell proliferation and suppression of apoptosis.

Authors:  Valentina V Nenasheva; Irina V Makarova; Ekaterina A Stepanenko; Stanislav A Antonov; Ekaterina V Novosadova; Anastasia R Narsullaeva; Larisa V Kozikova; Ekaterina A Polteva; Lyudmila A Sleptsova; Natalya A Shcherbatova; Nella V Khaidarova; Lyudmila E Andreeva; Vyacheslav Z Tarantul
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-05-21       Impact factor: 2.416

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.